Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.
Edward C A MarksTom M WilkinsonChris M FramptonLorraine SkeltonAnna P PilbrowTim G YandleChris J PembertonRobert N DoughtyGillian A WhalleyChris J EllisRichard W TroughtonMaurice C OwenNeil R PattinsonVicky A CameronA Mark RichardsSteven P GiesegBarry R PalmerPublished in: BMC cardiovascular disorders (2018)
Australian New Zealand Clinical Trials Registry. ACTRN12605000431628 . 16 September 2005, Retrospectively registered.
Keyphrases
- vascular endothelial growth factor
- clinical trial
- acute coronary syndrome
- endothelial cells
- genome wide
- percutaneous coronary intervention
- antiplatelet therapy
- gene expression
- randomized controlled trial
- phase ii
- binding protein
- coronary artery disease
- open label
- genome wide association
- double blind
- atrial fibrillation